Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen
in hospitals. A. baumannii infection has become a challenging problem in clinical practice …

Acinetobacter baumannii is one of the major pathogenic ESKAPE bacterium, which is
responsible for about more than 722,000 cases in a year, globally. Despite the alarming …

In parallel to the uncontrolled use of antibiotics, the emergence of multidrug-resistant
bacteria, like Acinetobacter baumannii, has posed a severe threat. A. baumannii …

Multidrug-resistant Acinetobacter baumannii (A. baumannii) infections are becoming more
prevalent all over the world. As a cost-effective and preventative method, vaccination seems …

Developing adjuvant vaccines to combat rising multidrug-resistant (MDR) Acinetobacter
baumannii (A. baumannii) infections is a promising and cost-effective approach. The aim of …

Background: Chitosan nanoparticles (CSNP) are becoming a popular alternative for
delivering nucleic acids to tissues for gene transfer (gene therapy). The size and …

Tackling antimicrobial resistance requires the development of new drugs and vaccines.
Artificial intelligence (AI) assisted computational approaches offer an alternative to the …

With the continuous evolution of bacteria, the global antimicrobial resistance health threat is
causing millions of deaths yearly. While depending on antibiotics as a primary treatment has …

Acinetobacter baumannii is a gram-negative bacillus prevalent in nature, capable of thriving
under various environmental conditions. As an opportunistic pathogen, it frequently causes …

Neisseria gonorrhoeae (Ngo) has emerged as a global threat leading to one of the most
common sexually transmitted diseases in the world. It has also become one of the leading …